Netarsudil mesylate - Alcon
At a glance
- Drug Originator Duke University Medical Center
- Drug Licenced by Alcon; Santen Pharmaceutical
- Drug Class Antiglaucomas; Eye disorder therapies; Isoquinolines; Small molecules
- Mechanism of Action Rho-associated kinase inhibitors
- USA Patent Applicants ALCON LABS INC
- USA Patents 24
- NDAs 1
- International Patents 68
- Patent Applications 108
Table of Contents
Disclaimer